CABRI is proudly dedicated to research new treatments for rare diseases. To support this effort, we offer research grants to individual principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development of our mission.
Eligible applicants include domestic and international researchers alike, along with domestic and international group collaborations. Our grants are open to investigators of any career stage who are capable of leading an independent research study and supervising personnel. Funds may only be used for research. CABRI does not fund institutional overhead costs.
PAST GRANT RECIPIENTS
2018 Grant Recipients
$50,000 – Dr. Sven-Erik Dahlen, Karolinska Institute Research entitled: “Inhibition of prostaglandin D2 biosynthesis: an unmet need in many inadequately treated diseases.”
$50,000 – Michael Holinstadt, University of Michigan Research entitled: “Assessing whether 12-LOX deficiency reduces incidences of thrombocytopenia.”Dr. Sven-Erik Dahlen
2017 Grant Recipients
$59,200 – Dr. Peter Krieg, DKFZ, Research entitled: ““Novel therapeutic approached for the treatment of autosomal recessive congenital ichthyoses (ARCI).”
$17,000 – Dr. Stefan Zwingenberger, University of Dresden Research entitled: “Enhancement of bone regeneration by functionalization of various bone substitution materials with a novel and potent lactam acetylene EP4 receptor agonist (KMN-159).”
2016 Grant Recipients
$50,000 – Migual Gijon, University of Colorado-Denver Research entitled: “Lipid mediators in urine as indicators of ongoing inflammation and progression of disease when mice are injected with maresin 1 into the peritoneal cavity.”
2015 Grant Recipients
$59,200 – Dr. Peter Krieg, DKFZ Research entitled: “Novel therapeutic approach for the treatment of autosomal recessive congenital ichthyoses (ARCI).”